In the United States, about 12,000 premature infants develop intraventricular hemorrhage
(IVH) every year. The incidence of moderate-to-severe IVH has remained almost stationary …

Background There is widespread, increasing use of magnesium sulphate in obstetric
practice for pre-eclampsia, eclampsia, and preterm fetal neuroprotection; benefit for …

There is an important unmet need to improve long term outcomes of encephalopathy for
preterm and term infants. Meta-analyses of large controlled trials suggest that maternal …

Prevention of neurologic disability associated with preterm birth is one of the major
challenges in current perinatal medicine. Magnesium sulfate (MgSO4), the focus of this …

Magnesium (Mg) is an essential mineral in the body, impacting the synthesis of
biomacromolecules, bone matrix development, energy production, as well as heart, nerve …

The ductus arteriosus (DA) is probably the most intriguing vessel in postnatal hemodynamic
transition. DA patency in utero is an active state, in which prostaglandin E2 (PGE2) and nitric …

Objective: Magnesium therapy has been studied extensively in pre-clinical and clinical trials
in multiple organ systems. Cerebrovascular diseases may benefit from its neuroprotective …

Objectıve The aim of this study is to develop a scoring system for the prediction of
intraventricular hemorrhage (IVH) in preterm infants in the first 7 days of life. Methods A …

Introduction To evaluate the effect of antenatal magnesium sulfate (MgSO4) on mortality and
morbidity outcomes related to the gastrointestinal system (GI) in preterm infants. Methods …

Being born preterm (prior to 37 weeks of completed gestation) is a leading cause of
childhood death up to five years of age, and is responsible for the demise of around one …